Maxima Mendez: Complete Results of the Pelacarsen Cardiovascular Outcomes Study at AHA 2026
Maxima Mendez, Chief Executive Officer at Cli-Lipid, shared a post on X about a recent article by Leslie Cho et al, published in The New England Journal of Medicine, adding:
“Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a), New England Journal of Medicine.
Complete Study Presented today at AHA 2026, Chicago, IL.”
Title: Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a)
Authors: Leslie Cho, Stephen J. Nicholls, Seth Frndak, Kathy Wolski, Børge G. Nordestgaard, Brian Manning, Eran Leitersdorf, Ulf Landmesser, Venu Menon, Jackie McCluskey, Michael J. Blaha, Ryuichi Morishita, A. Michael Lincoff, Ziqiang Zhao, Jing Wang, Raul D. Santos, Ioanna Gouni-Berthold, Sotirios Tsimikas, Anastasia Lesogor, Hui Cao, Steven E. Nissen
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 10, 2026, 13:10Alan Nurden։ How Aberrant Splicing Disrupts Megakaryocyte Development in TAR Syndrome
-
Nov 10, 2026, 13:10Masanori Aikawa: NEK7 Research Earns Top Honors at AHA 2026
-
Nov 10, 2026, 12:57Chokri Ben Lamine: The Hidden Risk of RBC Alloimmunization in SCD, Thalassemia and HSCT
-
Nov 10, 2026, 12:47Jamie Nash։ RBC-Derived EVs Show Greater Procoagulant Potential
-
Nov 10, 2026, 11:14Judith Catella: SVC Filters in Upper Extremity DVT Thrombectomy
-
Nov 10, 2026, 11:11Roberta Gualtierotti: Oral Signs of Systemic Immune-Mediated Diseases
-
Nov 10, 2026, 11:08Tim Brümmendorf: FlowFISH in New ASH Guidelines for Aplastic Anemia
-
Nov 10, 2026, 11:01Sophia Delicou: Bronze Award for Hippokration’s Hemoglobinopathy Centre
-
Nov 10, 2026, 10:16Building Future Leaders in Transfusion Medicine – TRAM Leadership Program